Bard Associates Inc Adamis Pharmaceuticals Corp Transaction History

Bard Associates Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$0.33 - $0.66 $40,953 - $81,906	-124,100 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$0.33 - $0.89 $66 - $178	-200 Reduced 0.16%	124,100 $44,000
Q4 2019 Feb 13, 2020	SELL	$0.51 - $1.26 $29,261 - $72,292	-57,375 Reduced 31.58%	124,300 $87,000
Q4 2019 Feb 13, 2020	BUY	$0.51 - $1.26 $26,469 - $65,394	51,900 Added 39.99%	181,675 $1.12 Million
Q3 2019 Nov 14, 2019	SELL	$0.7 - $1.46 $4,059 - $8,468	-5,800 Reduced 4.28%	129,775 $91,000
Q2 2019 Aug 13, 2019	SELL	$1.26 - $2.23 $2,803 - $4,961	-2,225 Reduced 1.61%	135,575 $176,000
Q1 2019 May 13, 2019	SELL	$2.02 - $3.22 $5,050 - $8,050	-2,500 Reduced 1.78%	137,800 $291,000
Q4 2018 Feb 13, 2019	SELL	$2.1 - $3.21 $17,850 - $27,285	-8,500 Reduced 5.71%	140,300 $316,000
Q3 2018 Nov 14, 2018	SELL	$2.25 - $4.8 $6,750 - $14,400	-3,000 Reduced 1.98%	148,800 $521,000
Q2 2018 Aug 15, 2018	SELL	$3.2 - $4.7 $3,680 - $5,405	-1,150 Reduced 0.75%	151,800 $486,000
Q1 2018 May 14, 2018	BUY	$2.55 - $4.85 $4,845 - $9,215	1,900 Added 1.26%	152,950 $535,000
Q4 2017 Feb 13, 2018	SELL	$3.5 - $5.65 $700 - $1,130	-200 Reduced 0.13%	151,050 $665,000
Q3 2017 Nov 14, 2017	BUY	$4.5 - $5.65 $680,625 - $854,562	151,250	151,250 $790,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Bard Associates Inc with notifications on news.